Contact Us: 01282 426380
KM Financial Solutions | UPDATE 2-Novartis sickle-cell drug gets U.S. FDA approval
55703
post-template-default,single,single-post,postid-55703,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 2-Novartis sickle-cell drug gets U.S. FDA approval

14 Nov UPDATE 2-Novartis sickle-cell drug gets U.S. FDA approval

Posted at 20:58h in News by
0 Likes
Novartis AG on Friday won U.S.
approval for its experimental sickle cell disease drug, Adakveo,
making it the first of several proposed new therapies designed
to offer lasting relief for patients with the debilitating blood
disease to get U.S. regulatory clearance.

No Comments

Sorry, the comment form is closed at this time.